CORPORATE TRAVEL MANAGEMENT LIMITED (CTD)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CTD - CORPORATE TRAVEL MANAGEMENT LIMITED

FNArena Sector : Travel, Leisure & Tourism
Year End: June
GICS Industry Group : Consumer Services
Debt/EBITDA: 0.2
Index: ASX200 | ASX300 | ALL-ORDS

Corporate Travel is an Australian provider of travel solutions to the corporate market. Founded in 1994, the company listed on the ASX in 2010.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$14.94

23 Jan
2025

0.010

OPEN

$14.89

0.07%

HIGH

$14.94

316,835

LOW

$14.77

TARGET
$14.201 -4.9% downside
OTHER COMPANIES IN THE SAME SECTOR
AIA . AIZ . CEH . CHL . EVT . EXP . FLT . HLO . KLS . QAN . SDR . SKO . SST . THL . VGL . VRL . VVA . WEB . WJL .
FNARENA'S MARKET CONSENSUS FORECASTS
CTD: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 57.9 77.1 xxx
DPS (cps) xxx 29.0 31.9 xxx
EPS Growth xxx 9.0% 33.2% xxx
DPS Growth xxx 3.6% 10.1% xxx
PE Ratio xxx N/A 19.6 xxx
Dividend Yield xxx N/A 2.1% xxx
Div Pay Ratio(%) xxx 50.1% 41.4% xxx

Dividend yield today if purchased 3 years ago: 1.39%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.92

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/08 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx57.9
DPS All xxxxxxxxxxxxxxx29.0
Sales/Revenue xxxxxxxxxxxxxxx707.7 M
Book Value Per Share xxxxxxxxxxxxxxx812.2
Net Operating Cash Flow xxxxxxxxxxxxxxx126.8 M
Net Profit Margin xxxxxxxxxxxxxxx11.93 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx7.19 %
Return on Invested Capital xxxxxxxxxxxxxxx7.02 %
Return on Assets xxxxxxxxxxxxxxx4.91 %
Return on Equity xxxxxxxxxxxxxxx7.19 %
Return on Total Capital xxxxxxxxxxxxxxx11.00 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx64.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx10 M
Long Term Debt xxxxxxxxxxxxxxx29 M
Total Debt xxxxxxxxxxxxxxx39 M
Goodwill - Gross xxxxxxxxxxxxxxx923 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx135 M
Price To Book Value xxxxxxxxxxxxxxx1.63

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx47.6 M
Capex % of Sales xxxxxxxxxxxxxxx6.72 %
Cost of Goods Sold xxxxxxxxxxxxxxx552 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx21 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx7 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Shaw and Partners

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

01/11/2024

3

Downgrade to Hold from Add

$13.50

-9.64%

For what management could control, Morgans deems the AGM trading update by Corporate Travel Management was positive, but a recent UK government announcement is set to weigh.

The downside cannot as yet be quantified for the company's largest contract after the UK government announced its intention to reduce spending, including on travel, explains the broker.

Given this announcement creates uncertainty around the company's Europe near-term earnings, the analysts downgrade to Hold from Add. The target also falls to $13.50 from $15.95.

Elsewhere, the trading updated showed North America and the A&NZ region have started the year strongly, according to Morgans.

FORECAST
Morgans forecasts a full year FY25 dividend of 27.90 cents and EPS of 72.90 cents.
Morgans forecasts a full year FY26 dividend of 34.60 cents and EPS of 83.40 cents.

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxxxx xx xxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

3

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

xx/xx/xxxx

3

xxxxxx xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Canaccord Genuity

04/11/2024

1

Buy

$14.40

-3.61%

Corporate Travel Management's 1Q25 update highlights stable performance in A&NZ and US segments, offsetting weaknesses in Europe and Asia due to potential government budget cuts and pricing deflation, particularly in the UK, Canaccord Genuity explains.

Despite these challenges, the company won a position on the US Federal Government panel and secured a three-year extension with the UK Government as a sole provider, with new client wins valued at over $0.4bn in FY25.

Management retained FY25 EBITDA guidance at $210m, though consensus may adjust downward based on recent UK budget constraints, the broker suggests.

No change to Buy rating and $14.40 target.

FORECAST
Canaccord Genuity forecasts a full year FY25 dividend of 37.70 cents and EPS of 75.40 cents.
Canaccord Genuity forecasts a full year FY26 dividend of 43.40 cents and EPS of 86.90 cents.

Jarden

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

CTD STOCK CHART